Amikacin Sulfate
Active substance: amikacin
INJECTION, SOLUTION · AMIKACIN SULFATE 250 mg/mL
United StatesActive
Marketing holder: Fresenius Kabi USA, LLC
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 3
Composition
- AMIKACIN SULFATE · 250 mg/mL
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 33 |
|
| EU 2 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-389f-767b-9a86-20845f260ea7,01a1208c-3b49-7de7-a913-fc1a989d94cd,01a1208c-3b4a-7eba-bf2b-fd308a4d381b,01a1208e-a694-7823-91cf-2ddd0b8e93b1,01a12090-8f53-7494-84ad-707cf131e27c;count=12 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 63323-815
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAMUSCULAR, INTRAVENOUS
Sources
- product · openFDA NDC · 63323-815 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 63323-815 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 63323-815 · Verified 2026-10-09 · open in source